Production (Stage)
Apyx Medical Corporation
APYX
$1.54
-$0.12-7.23%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 31.01M | 31.74M | 28.01M | 32.68M | 37.28M |
| Total Receivables | 11.65M | 15.58M | 13.04M | 12.71M | 12.49M |
| Inventory | 7.69M | 7.56M | 9.00M | 9.32M | 9.80M |
| Prepaid Expenses | 1.51M | 1.56M | 2.11M | 1.96M | 2.36M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 51.85M | 56.44M | 52.16M | 56.67M | 61.93M |
|
|
|||||
| Total Current Assets | 51.85M | 56.44M | 52.16M | 56.67M | 61.93M |
| Net Property, Plant & Equipment | 6.54M | 6.74M | 6.78M | 6.91M | 6.89M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1.77M | 1.66M | 1.79M | 1.81M | 1.89M |
| Total Assets | 60.16M | 64.84M | 60.72M | 65.39M | 70.71M |
|
|
|||||
| Total Accounts Payable | 2.31M | 2.62M | 1.91M | 2.35M | 2.10M |
| Total Accrued Expenses | 3.09M | 3.46M | 3.30M | 3.66M | 3.73M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 374.00K | 355.00K | 350.00K | 333.00K | 376.00K |
| Total Finance Division Other Current Liabilities | 3.74M | 4.29M | 3.99M | 4.30M | 4.35M |
| Total Other Current Liabilities | 3.74M | 4.29M | 3.99M | 4.30M | 4.35M |
| Total Current Liabilities | 9.51M | 10.72M | 9.56M | 10.64M | 10.56M |
|
|
|||||
| Total Current Liabilities | 9.51M | 10.72M | 9.56M | 10.64M | 10.56M |
| Long-Term Debt | 34.13M | 33.89M | 33.85M | 33.63M | 33.41M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 4.42M | 4.52M | 4.64M | 4.74M | 4.84M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 1.46M | 1.38M | 1.47M | 1.46M | 1.45M |
| Total Liabilities | 49.52M | 50.51M | 49.52M | 50.47M | 50.25M |
|
|
|||||
| Common Stock & APIC | 92.57M | 92.12M | 84.32M | 83.33M | 82.28M |
| Retained Earnings | -82.06M | -77.91M | -73.28M | -68.58M | -62.02M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 10.51M | 14.21M | 11.04M | 14.75M | 20.25M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 10.51M | 14.21M | 11.04M | 14.75M | 20.25M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | 133.00K | 125.00K | 156.00K | 177.00K | 207.00K |
| Total Equity | 10.64M | 14.34M | 11.20M | 14.92M | 20.46M |
|
|
|||||